BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Gulf Coast Consortia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Gulf Coast Consortia
X-ORIGINAL-URL:https://www.gulfcoastconsortia.org
X-WR-CALDESC:Events for Gulf Coast Consortia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20220815T100000
DTEND;TZID=America/Chicago:20220819T150000
DTSTAMP:20260408T072749
CREATED:20220629T132011Z
LAST-MODIFIED:20220629T132040Z
UID:10000989-1660557600-1660921200@www.gulfcoastconsortia.org
SUMMARY:Foundations of Cancer Therapeutics: Commercialization
DESCRIPTION:The GCC Innovative Drug Discovery and Development (IDDD) Consortium invites you to register to audit this short “crash” course that will cover various aspects of therapeutics commercialization career opportunities within this space.  Though cancer will be highlighted\, the various aspects of therapeutics commercialization and careers will be largely disease-agnostic\, so all are welcome.  Topics to be covered include 1) understanding disease\, need\, target population\, market\, and competitive landscape; 2) end game development goals and target produce profile; 3) strategies for when to file invention disclosures and patents and when to license; 4) commercialization strategies; 5) Funding; 6) preclinical/IND-enabling studies; 7) clinical trials; 8) NDA and post approval; and 9) the final day highlighting the Houston therapeutics landscape and small biotech companies.  Career panel discussions will take place in the afternoon of each day.  Confirmed speakers include Sarah Hein (TMCi)\, Phil Jones (MDA)\, Wei Wan (TAMU)\, Larry Hope (MDA)\, John Shultz (HMRI)\, Suzanne Tomlinson (GCC)\, Enrique Gomez (TMCi)\, and Andrew Strong (Hogan Lovells).  Those who register to audit the course will participate via Zoom.  The course will start at 10 am each day and end by 3 pm.
URL:https://www.gulfcoastconsortia.org/event/foundations-of-cancer-therapeutics-commercialization/
CATEGORIES:GCCIDDD
END:VEVENT
END:VCALENDAR